Randall A. Prince

2.8k total citations
79 papers, 2.2k citations indexed

About

Randall A. Prince is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Randall A. Prince has authored 79 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pharmacology, 35 papers in Infectious Diseases and 21 papers in Epidemiology. Recurrent topics in Randall A. Prince's work include Antibiotics Pharmacokinetics and Efficacy (29 papers), Antifungal resistance and susceptibility (23 papers) and Antibiotic Resistance in Bacteria (20 papers). Randall A. Prince is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (29 papers), Antifungal resistance and susceptibility (23 papers) and Antibiotic Resistance in Bacteria (20 papers). Randall A. Prince collaborates with scholars based in United States, Singapore and China. Randall A. Prince's co-authors include Dimitrios P. Kontoyiannis, Russell E. Lewis, Nathan P. Wiederhold, Jingduan Chi, Vincent H. Tam, Issam Raad, Kenneth V. I. Rolston, David R. Andes, Jack L. LeFrock and Jingguo Hou and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Journal of Allergy and Clinical Immunology.

In The Last Decade

Randall A. Prince

79 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Randall A. Prince United States	25	1.3k	904	703	368	242	79	2.2k
Fumiaki Ikeda Japan	26	1.1k 0.8×	881 1.0×	525 0.7×	286 0.8×	404 1.7×	77	2.3k
Erika J. Ernst United States	28	1.3k 1.0×	1.0k 1.1×	603 0.9×	235 0.6×	285 1.2×	71	2.7k
Alexander J. Lepak United States	28	1.4k 1.1×	1.0k 1.1×	669 1.0×	405 1.1×	239 1.0×	80	2.0k
Charalampos Antachopoulos Greece	28	1.3k 1.0×	1.3k 1.4×	414 0.6×	547 1.5×	260 1.1×	79	2.4k
Ken Bartizal United States	27	1.9k 1.5×	1.3k 1.4×	535 0.8×	125 0.3×	425 1.8×	49	2.6k
Daniel J. Sheehan United States	17	1.6k 1.2×	1.0k 1.1×	302 0.4×	149 0.4×	386 1.6×	35	2.6k
Weiguo Liu United States	30	1.2k 0.9×	960 1.1×	1.3k 1.9×	872 2.4×	509 2.1×	65	3.4k
Raymond P. Smith United States	26	776 0.6×	1.1k 1.2×	425 0.6×	397 1.1×	530 2.2×	101	2.6k
N X Chin United States	28	633 0.5×	759 0.8×	1.4k 1.9×	979 2.7×	412 1.7×	62	2.3k
R. Williamson France	28	826 0.6×	397 0.4×	390 0.6×	572 1.6×	650 2.7×	60	3.1k

Countries citing papers authored by Randall A. Prince

Since Specialization

Citations

This map shows the geographic impact of Randall A. Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randall A. Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randall A. Prince more than expected).

Fields of papers citing papers by Randall A. Prince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Randall A. Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randall A. Prince. The network helps show where Randall A. Prince may publish in the future.

Co-authorship network of co-authors of Randall A. Prince

This figure shows the co-authorship network connecting the top 25 collaborators of Randall A. Prince. A scholar is included among the top collaborators of Randall A. Prince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Randall A. Prince. Randall A. Prince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rolston, Kenneth V. I., et al.. (2023). In vitroactivity of eravacycline and comparator agents against bacterial pathogens isolated from patients with cancer. JAC-Antimicrobial Resistance. 5(2). dlad020–dlad020. 9 indexed citations

Rolston, Kenneth V. I., Ruth Reitzel, Samuel A. Shelburne, et al.. (2022). In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer. Journal of Global Antimicrobial Resistance. 29. 1–6. 2 indexed citations

Rolston, Kenneth V. I., et al.. (2018). In vitro activity of tedizolid and comparator agents against clinical Gram-positive isolates recovered from patients with cancer. Diagnostic Microbiology and Infectious Disease. 91(4). 351–353. 4 indexed citations

Aitken, Samuel L, Jeffrey J. Tarrand, Lalitagauri M. Deshpande, et al.. (2016). High Rates of Nonsusceptibility to Ceftazidime-avibactam and Identification of New Delhi Metallo-β-lactamase Production inEnterobacteriaceaeBloodstream Infections at a Major Cancer Center: Table 1.. Clinical Infectious Diseases. 63(7). 954–958. 55 indexed citations

Rolston, Kenneth V. I., et al.. (2016). Time-kill determination of the bactericidal activity of telavancin and vancomycin against clinical methicillin-resistant Staphylococcus aureus isolates from cancer patients. Diagnostic Microbiology and Infectious Disease. 87(4). 338–342. 8 indexed citations

Rolston, Kenneth V. I., Weiqun Wang, Lior Nesher, et al.. (2014). In vitro activity of telavancin compared with vancomycin and linezolid against Gram-positive organisms isolated from cancer patients. The Journal of Antibiotics. 67(7). 505–509. 8 indexed citations

Rotschafer, John C., et al.. (2013). Polymyxins: Wisdom Does Not Always Come With Age. Clinical Infectious Diseases. 57(6). 877–883. 33 indexed citations

Rolston, Kenneth V. I., et al.. (2013). Spectrum of Gram-positive bacteraemia and in vitro activities of daptomycin, linezolid and vancomycin against organisms isolated from cancer patients. International Journal of Antimicrobial Agents. 41(6). 516–520. 8 indexed citations

Chaftari, Anne‐Marie, Ray Hachem, Elizabeth Ramos, et al.. (2012). Comparison of Posaconazole Versus Weekly Amphotericin B Lipid Complex for the Prevention of Invasive Fungal Infections in Hematopoietic Stem-Cell Transplantation. Transplantation. 94(3). 302–308. 33 indexed citations

10.

Lewis, Russell E., et al.. (2011). Voriconazole pre-exposure selects for breakthrough mucormycosis in a mixed model ofAspergillus fumigatus-Rhizopus oryzaepulmonary infection. Virulence. 2(4). 348–355. 34 indexed citations

11.

Yuan, Zhe, Kimberly R. Ledesma, Renu Singh, et al.. (2010). Quantitative Assessment of Combination Antimicrobial Therapy against Multidrug‐Resistant Bacteria in a Murine Pneumonia Model. The Journal of Infectious Diseases. 201(6). 889–897. 24 indexed citations

12.

Singh, Renu, et al.. (2009). Pharmacodynamics of moxifloxacin against a high inoculum of Escherichia coli in an in vitro infection model. Journal of Antimicrobial Chemotherapy. 64(3). 556–562. 16 indexed citations

13.

Stein, Gary E., et al.. (2009). Fungicidal activity of anidulafungin in serum from patients does not correlate to its susceptible breakpoint against Candida spp.. Journal of Antimicrobial Chemotherapy. 65(2). 374–376. 5 indexed citations

14.

Lewis, Russell E., Nathan P. Wiederhold, Randall A. Prince, & Dimitrios P. Kontoyiannis. (2005). In vitro pharmacodynamics of rapid versus continuous infusion of amphotericin B deoxycholate against Candida species in the presence of human serum albumin. Journal of Antimicrobial Chemotherapy. 57(2). 288–293. 13 indexed citations

15.

Hariprasad, Seenu M., Gaurav K. Shah, Jingduan Chi, & Randall A. Prince. (2005). Determination of aqueous and vitreous concentration of moxifloxacin 0.5% after delivery via a dissolvable corneal collagen shield device. Journal of Cataract & Refractive Surgery. 31(11). 2142–2146. 16 indexed citations

16.

Walker, Paul, Vincent H. Tam, Jie Willey, et al.. (2005). Subcutaneous Administration of Cefepime. Journal of Pain and Symptom Management. 30(2). 170–174. 23 indexed citations

17.

Prince, Randall A., et al.. (1997). A simple method for administering vancomycin in the spinal cord injured population. Archives of Physical Medicine and Rehabilitation. 78(5). 459–462. 1 indexed citations

18.

Anaissie, E., Dimitrios P. Kontoyiannis, S. E. Vartivarian, et al.. (1995). Safety, Plasma Concentrations, and Efficacy of High-Dose Fluconazole in Invasive Mold Infections. The Journal of Infectious Diseases. 172(2). 599–602. 102 indexed citations

19.

Prince, Randall A., Ed Casabar, Colin G. Adair, et al.. (1989). Effect of Quinolone Antimicrobials on Theophylline Pharmacokinetics. The Journal of Clinical Pharmacology. 29(7). 650–654. 23 indexed citations

20.

McElnay, James C., et al.. (1982). Effect of tetracycline hydrochloride on theophylline kinetics.. International Journal of Clinical Pharmacy. 446–448. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact